U of T Researchers Call for Greater Transparency in Vaccine Decision-Making

Feb 4, 2015

A group of University of Toronto researchers is urging the world’s health authorities to overhaul the way vaccine decisions are made and communicated, saying such decisions should no longer be made behind closed doors.

 

Professor Natasha Crowcroft

The decision by government authorities to include new vaccines on their countries’ schedules should be  open to public consultation and input, and the process should allow greater prominence to ethical considerations, they argue.

Babies today receive far more protection from disease through vaccination than children in previous generations, and the diseases that are targeted by newer vaccines are now relatively rare said Natasha Crowcroft, Associate Professor in the Department of Laboratory Medicine and Pathobiology. As a result, decisions about whether to schedule  additional vaccines are more difficult and require more than just scientific input  – and the traditional, closed-door method of deciding whether a new vaccine should be used is outmoded.

“Anything that undermines confidence in immunization is a bad idea,” says Crowcroft, who is also Chief of Infectious Diseases at Public Health Ontario. “We can’t just have a group of clever people go off into a room and make a decision. That process doesn’t work anymore.”

In a paper published Jan. 30 in the British Medical Journal , Crowcroft, along with professors Ross Upshur and Shelley Deeks of the Dalla Lana School of Public Health, calls for an internationally agreed-upon framework to provide clarity about the pros and cons of adding new vaccines to the schedule.

“Every country is facing the same decision,” says Crowcroft. “It has to be international because we’re all in this together. Disease can’t be turned back at the border. And every country is struggling with the same issue – there’s a crucial chunk missing from the decision-making process which undermines public confidence.”

The way in which British health authorities handled the decision against introducing a new vaccine in 2013 underscores the need for change, according to the authors. Authorities announced they were declining the vaccine for meningitis B, a rare but harsh disease affecting babies, because it was not cost effective – triggering a public outcry.

While it may have seemed easiest to put it in strictly economic terms, in reality, the initial decision to turn down the vaccine was far more complex, involving safety and effectiveness considerations, says Crowcroft. But the public never understood the nuances because such decisions are made behind closed doors. In the British case, this lack of transparency led to conspiracy theories, including the idea that industry had unduly influenced the proceedings.

The authors also believe that bio-ethicists should be involved in the decision-making process early on, when the risks and benefits of a new vaccine are being weighed. Ethical considerations, such as the opportunity cost of spending health care dollars on vaccinations,  should be integral to the assessment of the medical evidence and economic benefit of an immunization, they argue.

The paper can be viewed at http://www.bmj.com/content/350/bmj.h308
 

Tweets

Temerty Medicine
@uoftmedicine
RT : Have you listened to Ep 82 Making Strides: Amputation & Prosthetics yet? 🎧 Aristotle Domingo () shared his… https://t.co/HaGTiTk2u9
Temerty Medicine
@uoftmedicine
RT : To avoid a 'twindemic' health officials are telling Canadians to following guidelines for the pandemic, and to get… https://t.co/mvEkEwlqrA
Temerty Medicine
@uoftmedicine
“If we can't learn from it then it has little to no scientific value.” Scientists are challenging their colleagues… https://t.co/KcWqs2WNVe

Researchers are mobilizing against the novel SARS-CoV-2 coronavirus and COVID-19.

Make a gift and support their important work.
Sep 23 – Nov 11
Safer Opioid Prescribing
Course | 7:00am–9:00pm
Oct 5 – May 6
Academic Health Leadership Training – Now Accepting Applications 2020-2021 Cohort
Course | 8:00am–5:00pm
Oct 13 – Jun 8
Certificate Program in CPD Foundations
Course | 12:00pm–1:30pm
Oct 21 Creating AODA-Compliant Documents for the Web
Webinar | 10:30am–12:00pm
Oct 22 Medicine and the Machine: The Artificial Intelligence Health Revolution
Temerty Medicine Talk | 12:30pm–1:15pm
Oct 23 U of T Oncology Continuing Education Zoom Rounds - October 2020
Grand Rounds | 8:00am–9:00am
Oct
24 – 26
Organ Imaging Review
Symposium | 7:15am–5:15pm